サマリー

テストステロン補充療法の世界市場 2022-2026 年
Technavioはテストステロン補充療法市場を監視しており、2022-2026年の間に4億2087万ドルの成長が見込まれ、予測期間中にCAGR3.1％で加速しています。当レポートでは、テストステロン補充療法市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、人々の性腺機能低下症に対する認識を高めるための取り組み、慢性疾患の増加、発展途上国における未開発の潜在能力によって牽引されています。
テストステロン補充療法市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioのテストステロン補充療法市場は、以下のように区分されています。
製品別
- 注射剤
- 外用薬
- その他
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間のテストステロン補充療法市場の成長を促進する主な理由の1つとして、新しい治療アプローチの増加を挙げています。また、患者支援プログラムと新しい治療法の開発は、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。テストステロン補充療法市場に関する当レポートの対象領域は以下の通りです。
- テストステロン補充療法市場のサイジング
- テストステロン補充療法市場の予測
- テストステロン補充療法市場の産業分析
Technavioの堅牢なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AbbVie Inc.、Acerus Pharmaceuticals Corp.、Acrux Ltd.、Actiza Pharmaceutical Pvt. Ltd.を含む複数の主要テストステロン補充療法市場ベンダーについて詳細な分析を提供しています。Antares Pharma Inc.、Aytu BioPharma Inc.、Bausch Health Co. Inc.、Bayer AG、BIOTE MEDICAL LLC、Cipla Ltd.、Clarus Therapeutics Inc、Eli Lilly and Co.、Endo International Plc、Novartis AG、Pfizer Inc、Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., The Simple Pharma Co.UK Ltd.、Upsher Smith Laboratories LLC、Viatris Inc.などです。また、テストステロン補充療法市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略化し、活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/testosterone-replacement-therapy-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示しています。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Injectables - Market size and forecast 2021-2026
o Exhibit 28: Chart on Injectables - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Injectables - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Injectables - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Injectables - Year-over-year growth 2021-2026 (%)
o 5.4 Topicals - Market size and forecast 2021-2026
o Exhibit 32: Chart on Topicals - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Topicals - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Topicals - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Topicals - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Product
o Exhibit 40: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share by geography 2021-2026 (%)
o Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.9 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 82: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 AbbVie Inc.
o Exhibit 89: AbbVie Inc. - Overview
o Exhibit 90: AbbVie Inc. - Product / Service
o Exhibit 91: AbbVie Inc. - Key offerings
o 10.4 Acerus Pharmaceuticals Corp.
o Exhibit 92: Acerus Pharmaceuticals Corp. - Overview
o Exhibit 93: Acerus Pharmaceuticals Corp. - Product / Service
o Exhibit 94: Acerus Pharmaceuticals Corp. - Key offerings
o 10.5 Antares Pharma Inc.
o Exhibit 95: Antares Pharma Inc. - Overview
o Exhibit 96: Antares Pharma Inc. - Product / Service
o Exhibit 97: Antares Pharma Inc. - Key news
o Exhibit 98: Antares Pharma Inc. - Key offerings
o 10.6 Bayer AG
o Exhibit 99: Bayer AG - Overview
o Exhibit 100: Bayer AG - Business segments
o Exhibit 101: Bayer AG - Key offerings
o Exhibit 102: Bayer AG - Segment focus
o 10.7 Clarus Therapeutics Inc.
o Exhibit 103: Clarus Therapeutics Inc. - Overview
o Exhibit 104: Clarus Therapeutics Inc. - Product / Service
o Exhibit 105: Clarus Therapeutics Inc. - Key offerings
o 10.8 Eli Lilly and Co.
o Exhibit 106: Eli Lilly and Co. - Overview
o Exhibit 107: Eli Lilly and Co. - Product / Service
o Exhibit 108: Eli Lilly and Co. - Key offerings
o 10.9 Endo International Plc
o Exhibit 109: Endo International Plc - Overview
o Exhibit 110: Endo International Plc - Business segments
o Exhibit 111: Endo International Plc - Key news
o Exhibit 112: Endo International Plc - Key offerings
o Exhibit 113: Endo International Plc - Segment focus
o 10.10 Novartis AG
o Exhibit 114: Novartis AG - Overview
o Exhibit 115: Novartis AG - Business segments
o Exhibit 116: Novartis AG - Key offerings
o Exhibit 117: Novartis AG - Segment focus
o 10.11 Pfizer Inc.
o Exhibit 118: Pfizer Inc. - Overview
o Exhibit 119: Pfizer Inc. - Product / Service
o Exhibit 120: Pfizer Inc. - Key news
o Exhibit 121: Pfizer Inc. - Key offerings
o 10.12 The Simple Pharma Co. UK Ltd.
o Exhibit 122: The Simple Pharma Co. UK Ltd. - Overview
o Exhibit 123: The Simple Pharma Co. UK Ltd. - Product / Service
o Exhibit 124: The Simple Pharma Co. UK Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 125: Inclusions checklist
o Exhibit 126: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 127: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 128: Research methodology
o Exhibit 129: Validation techniques employed for market sizing
o Exhibit 130: Information sources
o 11.5 List of abbreviations
o Exhibit 131: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Injectables - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Injectables - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Injectables - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Injectables - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Topicals - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Topicals - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Topicals - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Topicals - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Product ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share by geography 2021-2026 (%)
Exhibits43: Data Table on Market share by geography 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity by geography ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Acerus Pharmaceuticals Corp. - Overview
Exhibits93: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits94: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits95: Antares Pharma Inc. - Overview
Exhibits96: Antares Pharma Inc. - Product / Service
Exhibits97: Antares Pharma Inc. - Key news
Exhibits98: Antares Pharma Inc. - Key offerings
Exhibits99: Bayer AG - Overview
Exhibits100: Bayer AG - Business segments
Exhibits101: Bayer AG - Key offerings
Exhibits102: Bayer AG - Segment focus
Exhibits103: Clarus Therapeutics Inc. - Overview
Exhibits104: Clarus Therapeutics Inc. - Product / Service
Exhibits105: Clarus Therapeutics Inc. - Key offerings
Exhibits106: Eli Lilly and Co. - Overview
Exhibits107: Eli Lilly and Co. - Product / Service
Exhibits108: Eli Lilly and Co. - Key offerings
Exhibits109: Endo International Plc - Overview
Exhibits110: Endo International Plc - Business segments
Exhibits111: Endo International Plc - Key news
Exhibits112: Endo International Plc - Key offerings
Exhibits113: Endo International Plc - Segment focus
Exhibits114: Novartis AG - Overview
Exhibits115: Novartis AG - Business segments
Exhibits116: Novartis AG - Key offerings
Exhibits117: Novartis AG - Segment focus
Exhibits118: Pfizer Inc. - Overview
Exhibits119: Pfizer Inc. - Product / Service
Exhibits120: Pfizer Inc. - Key news
Exhibits121: Pfizer Inc. - Key offerings
Exhibits122: The Simple Pharma Co. UK Ltd. - Overview
Exhibits123: The Simple Pharma Co. UK Ltd. - Product / Service
Exhibits124: The Simple Pharma Co. UK Ltd. - Key offerings
Exhibits125: Inclusions checklist
Exhibits126: Exclusions checklist
Exhibits127: Currency conversion rates for US$
Exhibits128: Research methodology
Exhibits129: Validation techniques employed for market sizing
Exhibits130: Information sources
Exhibits131: List of abbreviations